# Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration

> **NCT02651038** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 10 (actual)

## Conditions studied

- Candida Sepsis

## Interventions

- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT02651038
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-01
- **Final completion:** 2016-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02651038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02651038, "Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02651038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
